Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB

Medroxyprogesterone acetate (MPA) is the main conservative treatment for endometrial cancer (EC) patients desirable to preserve fertility and those who cannot suffer from surgery. Considering the high incidence of progestin resistance and recurrence of MPA treatment, we reproposed antipsychotics chl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yunxia, Wu, Huiwen, Yang, Linlin, Huang, Ting, Li, Jian, Gong, Xiaodi, Li, Lijuan, Sun, Xiao, Mao, Fei, Wang, Yudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087176/
https://www.ncbi.nlm.nih.gov/pubmed/33937078
http://dx.doi.org/10.3389/fonc.2021.665832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087176/
https://www.ncbi.nlm.nih.gov/pubmed/33937078
http://dx.doi.org/10.3389/fonc.2021.665832

Ejemplares similares